Drug Manufacturers - Specialty & Generic · Fort Lauderdale, Florida, United States
$0.42
-5.51% (-$0.02)2026-05-26
Revenue$9.6M
Net Income-$2.2M
EPS$-0.44
Gross Margin32.2%
Market Cap$1.1M
Price Performance
Historical data including institutional events
Loading price data...
Company Profile
S
Steve Slilaty
CEO & Executive Director
Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada.
It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments.
The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer.
It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products.
In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications.
Sunshine The company is based in Fort Lauderdale, Florida.